YWSP Mission Statement:
The Yellow Warriors Society Philippines is a nationwide, community-based, voluntary health organization dedicated to promote a healthy and productive society by fighting and preventing Hepatitis B and C as major health problems in the Philippines, crashing all forms of discrimination upon hepatitis B and C carriers, and diminishing suffering from it through advocacy, research, education, and service.
8-Point Objective
The following are the objectives for which this organization has been organized, to wit:
a. Educate the people on the Hepatitis B and C Virus (HBV/HCV) to avoid any misconceptions on the disease;
b. Advocate a healthy living;.
c. Promote a fair environment for all HBV/HCV carriers in the society most particularly in the labor sector;
d. Help HBV/HCV carriers who are experiencing discrimination, depression, and anxiety by providing counselling and other activities;
e. Advocate the free or low cost screening and vaccination especially for newborn babies and children against HBV/HCV;
f. Promote quality but low cost hospitalization, laboratory tests and medicines for the HBV/HCV carriers and other diseases;
g. Promote research and clinical studies on HBV/HCV and other related diseases; and
h. Support individuals, non-government or government organizations who advocate the same objective as the Yellow Warriors Society Philippines.
YWSP Core Values:
"We CARE about our health and we believe that we need to be INVOLVED to achieve our desired CHANGE."
Hepatitis and PWID/harm reduction
11:35 – 11:40
Chair: WHO – Intro and set the scene.
11:40 – 11:55
Co-chair: EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe.
11:55 – 12:00
ID 29: Ema Pos (not yet registered)
Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation.
12:05 – 12:10
ID 152: Brian Conway (Registered in person)
Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.
12:10 – 12:15
ID 212: Jasmine West (not yet registered)
Title: From lived experience to lived expertise: a syndemic approach.
12:15 – 12:20
ID: 299 Mercy Nyakowa (Registered in person)
Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya
12:20 – 12:25
ID: 133 Nalinikanta Rajkumar (Registered in person)
Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?
12:25 – 12:30
Q&A and closing remarks
tHIS
IS
BEN’S
BIG
TEST
effective case finding strategies
Supported by Vir Biotechnology, Inc
During this session you will hear from hepatitis Delta expert, Dr. Maria Buti, and a patient who has lived with hepatitis Delta in a panel discussion moderated by Dr. Carey Hwang, Chief Medical Officer (interim) of Vir Biotechnology. This panel will inform perspectives on patient needs, opportunities for enhanced screening, and strengthening linkages to care.
Session Agenda
14:40 – 14:45
Panel overview and introductions facilitated by Dr Carey Hwang (Vir Biotechnology)
14:45 – 15:05
Panel discussion: Dr Maria Buti (University Hospital Vall d’Hebron, Spain), Milanka Barbosa, Dr Carey Hwang (Chief Medical Officer interim), Vir Biotechnology
15:05 – 15:10
Final remarks and close